Dr. Amita Mahajan

Senior Consultant

32 years of experience

Pediatric Oncologists

MD, MBBS

Indraprastha Apollo Hospital, New Delhi

English

Consultation Fee ₹ 2000

Book an Appointment

About Dr. Amita Mahajan

Dr. Amita Mahajan, a renowned Pediatric Oncologist in India, has over 32 years of experience.
Her expertise lies in the treatment and management of Leiomyosarcoma, Lymphoplasmacytic Lymphoma, Malignancy, Malignant Fibrous Histiocytoma, Small Cell Lung Cancer, Small Intestine Cancer, Brain Cancer Treatment, Familial Tumoral Calcinosis, Ewing's Sarcoma, etc.
Her expertise in treating severe pediatric conditions is highly respected both nationally and internationally.
Dr. Mahajan has conducted numerous complex surgeries, including bone marrow transplants, in prominent hospitals in the UK.
Her educational qualifications include an MBBS from All India Institute of Medical Sciences, New Delhi, 1990, and an MD (Pediatrics) from All India Institute of Medical Sciences, New Delhi, 1992.
She has contributed significantly to the field through her research papers on Leukemia and other oncological issues.
She is affiliated with prestigious medical institutions such as the Royal College of Paediatrics & Child Health and the UK Children's Cancer Study Group, the Indian Academy of Paediatrics (IAP), the Oncology Indian Academy of Pediatrics, and the Royal College of Paediatrics & Child Health.

Education

MBBS, All India Institute of Medical Sciences, New Delhi, 1990
MD (Pediatrics), All India Institute of Medical Sciences, New Delhi, 1992

Paper Published

Thawani R, Moghe A, Idhate T, Kalra M, Mahajan A, Anderson KE. Porphyria Cutanea Tarda In A Child With Acute Lymphoblastic Leukemia.
QJM 2015, Dhamija M, Mahajan A, Kalra M, Virmani A. Deferasirox In Indian Children With Thalassemia Major: 3 Years Experience. Indian J Med Paediatr Oncol. 2013 Jan-Mar; 34(1): 16–20,Mittal L, Kalra M, Mahajan A.
Study Of Feasibility And Acceptability Of Subcutaneous Implantable Ports (SIPs) In Cancer Patients. Indian J Pediatr 2012; 79(12): 1601-1604. Fauzdar A, Mahajan A, Jain D, Mishra M, Raina V.
Amplification Of RUNX1 Gene In Two Cases Of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia J Clin Oncol 2009; Suppl: Abstr E21000, Fauzdar A, Jain D, Mishra M, Gupta N, Bhurani D, Mishra P, Mahajan A, Raina V.
Molecular Cytogenetic Study In Paediatric B-Lineage Acute Lymphoblastic Leukemia: A Collaborative Study Group From North India. J Clin Oncol 2008; Suppl: Abstr E20001.
Mahajan A, Faisal, Raina V. Acute Lymphoblastic Leukemia: Improving Outcomes In The Indian Scenario. Pediatr Blood & Cancer 2008; 48.Mahajan A, Sharma P. Pasha F. Feasibility Of Implantable Ports In The Indian Scenario. Pediatr Blood & Cancer 2007; 49: PG.045.
Mahajan A, Gupta V, Sharma P. A Study Of The Profile Of CNS Tumors Presenting To A New Paediatric Oncology Service In India. Pediatr Blood & Cancer 2006; 47: PJ.015.Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D, Fischer A, Friedrich W, Schulz AS: Working Party On Inborn Errors Of The European Blood & Marrow Transplant Group.
Severe Pulmonary Hypertension: A Frequent Complication Of Stem Cell Transplantation For Malignant Infantile Osteopetrosis. Br J Haematol 2004; 124(1): 63-71.
Booms C, Mahajan A, Jenney ME. Outcome Of Catheter Related Sepsis In Paediatric Oncology Patients. Arch Dis Child 2002; A14:G20. Mahajan A, Jenney ME, Doull I, Westmoreland D.
RSV Bronchiolitis In Immunocompromised Host - The Role Of Ribavirin? Published In The Welsh Paediatric Journal, May 2002. Mahajan A, Nirmal S, English MW, Jenney ME, Lazda E.
Acute Tumour Lysis In Hodgkin's Disease. Med Pediatr Oncol 2002; 39(1): 69-70.Mahajan A, Foot AB, English MW, Jenney ME. Survey Of Immunisation Practices Following Completion Of Chemotherapeutic Treatment. Arch Dis Child 2001; 84 (Suppl I): A29.
Chowdhry VP, Lal A, Pati HP, Arya LS. Hematological Responses To Hydroxyurea Therapy In Multitransfused Thalassemic Children. Indian J Paediatrics 1997: 64(3): 395-8.Lal A, Pati HP, Arya LS, Chowdhry VP.
Effect Of Myleran Therapy In Multitransfused Beta-Thalassemic Children. Indian Paediatrics 1995; 32(2): 238-41.